A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(3L)BSC33.
The breakpoints of Df(3L)BSC875 predicted from the Release 5 genomic coordinates of the progenitor P{XP}CG8600d02813 and PBac{WH}Ank2f02001 transposable element insertion sites are 3L:7328086 ;7654318 and the cytological breakpoints predicted from these coordinates are 65F5;66A8.